Genetic Epidemiology in Germany

Summary

Objectives: Genetic epidemiology investigates the role of genetic factors and their interaction with environmental factors (in a broad meaning) for the occurrence of diseases in human populations. Its aim is to undest-and the influence of genetics on the development of dis-eases, their course and the clinical implications, with the final goal to improve prevention, diagnostics and therapy.

Methods: Originally genetic epidemiology was understood as a specialized discipline with the main focus on family-based studies. The extraordinary development of genetics in the last decades – with respect of the understanding of the meaning of genes for human health, as well as by the availability of cost-effective high throughput methods in the lab, has opened enormous opportunities to study genetic factors. Now, genetic epidemiology and genetic statistics have a much broader application. In addition, access to large samples of patients or from the population is needed. This can be realized via biobanks.

Results: Large biobanks with 500,000 or more patients or participants from the general population are being established or planned in the UK, Japan or the US. However, in Germany only two smaller activities are ongoing, KORA-gen in the south and POPGEN in the north. Possibilities to reach larger numbers, based on existing cohorts or disease networks are discussed. Ethical boundary conditions have to be taken into account, which seem to improve due to the Opinion of the German National Ethics Council on Biobanks for Research. Furthermore, the activities of the German centers for Genetic Epidemiological Methods (GEMs) as research and support units for genetic statistics and epidemiological methodology are described.

Conclusions: Genetic epidemiology is based strongly on interdisciplinary collaboration and includes basics of genetics, elements of molecular biology to identify genes, population genetics, clinical medicine, and methodological disciplines as epidemiology, biostatistics and bioinformatics. In Germany the situation for this type of patient-based research has recently improved due to the National Genome Research Network (NGFN).

Keywords

Biobanking - genetics - epidemiology - bioethics

• References

• 1 NGFN – National Genomic Research Network (Nationales Genomforschungsnetz) www.rzpd.de/ngfn
• 2 DECODE – Genetics Biobank Iceland www.decode.com
• 3 Estonian genome project www.geenivaramu.ee
• 4 UK Biobank www.ukbiobank.ac.uk
• 5 Japan Biobank – The biobank Japan project www.atip.org/public/atip.reports.03/atip03.042.pdf
• 6 Collins FS. The case for a US prospective cohort study of genes and environment. Nature 2004; 429: 475-7.
• 7 P3G – public population project in genomics www.p3gconsortium.org
• 8 GENOMEUTWIN – European biobank www.genomeutwin.org
• 9 CARTaGENE – Canadian biobank www.p3gconsortium.org/Cartagene.cfm
• 10 COGENE – Coordination of Genomes research across Europe http://forum.europa.eu.int/irc/rtd/cogene/info/data/pub/rightframe.htm
• 11 Eaton W. The logic for a conception-to-death cohort study. Ann Epidemiol 2002; 12: 445-51.
• 12 Knoppers BM, Fecteau C. Human genomic databases: a global public good?. Eur J Health Law 2003; 10: 27-41.
• 13 Knoppers BM. Biobanks: simplifying consent. Nat Rev Genet 2004; 5: 485
• 14 Willett WC. Balancing life-style and genomics research for disease prevention. Science 2002; 296: 695-8.
• 15 Kaiser J. Population databases boom, from Iceland to the U.S. Science 2004; 296: 1158-61.
• 16 DAE/AKW (Deutsche Arbeitsgemeinschaft für Epidemiologie/Arbeitskreis Wissenschaft der Konferenz der Datenschutzbeauftragten des Bundes und der Länder): Epidemiologie und Datenschutz DuD (Datenschutz und Datensicherheit). 1999; 23: 100-2.
• 17 Wichmann HE. Datenschutz und Epidemiologie in Deutschland – Wege zur partnerschaftlichen Zusammenarbeit. Informatik, Biometrie und Epidemiologie in Medizin und Biologie 1999; 30: 35-44.
• 18 GEM (Genetic Epidemiological Methods) Munich – Ethics and confidentiality http://www2.gsf.de:6666/gem/ethik.htm
• 19 Wichmann HE, Jäger L, Taupitz J, Doppelfeld E. Ethik und genetische Epidemiologie. Deutsches Ärzteblatt 2002; 99: 2-4.
• 20 Wichmann HE. Epidemiologische Forschung und ihre Besonderheiten in Hinblick auf Ethik und Datenschutz. In Wiesing U, Simon A, von Engelhardt D. (eds.) Ethik in der medizinischen Forschung, Reihe Medizinethik, Band 13, Schattauer Verlag Stuttgart 2000: 164-80.
• 21 DAE (Deutsche Arbeitsgemeinschaft für Epidemiologie): Leitlinien und Empfehlungen zur Sicherung von Guter Epidemiologischer Praxis (GEP) (Redaktion: Bellach BM, Hense HH, Hoffmann W) www.daepi.de2004
• 22 German National Ethics Council (Nationaler Ethikrat). Biobanks for research – opinion (Biobanken für die Forschung). Saladruck, Berlin 2004 www.ethikrat.org
• 23 Wellbrock R. Biobanken für die Forschung – zur Stellungnahme des Nationalen Ethikrates. DUD (Datenschutz und Datensicherheit) 2004; 28: 561-5.
• 24 KORA (Kooperative Gesundheitsforschung in der Region Augsburg) www.gsf.de/KORA
• 25 Holle R, Wichmann HE. KORA – a research platform for population based health research. Gesundheitswesen 2005
• 26 Wichmann HE. KORA-gen: Internet-based access to sources for population genetics, population controls and a broad spectrum of disease phenotypes for genetic studies. Gesundheitswesen 2005
• 27 POPGEN – Population Genetics in Schleswig- Holstein www.popgen.de
• 28 SHIP – Study of Health in Pomerania http://fodb.uni-greifswald.de/projekt.php?page=details&show=630
• 29 EPIC – European Prospective Investigation into Cancer and nutrition www.iarc.fr/EPIC
• 30 Heinz Nixdorf Recall-Studie www.recall-studie.uni-essen.de
• 31 BMBF – Kompetenznetze www.kompetenznetze.de
• 32 GEM – Centers for Genetic Epidemiological Methods within the National Genomic Research. Network (NGFN) www2.gsf.de:6666/gem/gems_germany
• 33 Tomas D. Statistical methods in genetic epidemiology. Oxford University Press; 2004: 11-30.